Dr. Tousi said the medication, which is called Lecanemab, was designed to reduce amyloid beta plaque in the brain. Amyloid beta plaque has been linked to Alzheimer’s disease. The medication does not treat symptoms of the disease but rather helps to slow down the progression of it.
From
To